Ardelyx Grants Stock Options & RSUs to New Employees
Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial | PDF | Chronic Kidney Disease | Therapy
Ardelyx
SEC Filing | Ardelyx, Inc.
Ardelyx Inc.(NASDAQ: ARDX)-Can it Continue to Outdo Estimates?
Ardelyx (@ardelyx) / X
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities | Ardelyx, Inc.
Ardelyx: Q3 Earnings Snapshot -October 31, 2023 at 07:30 am EDT | MarketScreener
Positive FDA AdCom votes for Ardelyx's tenapanor
Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis
ARDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 28, 2021 in the Class Action Filed on Behalf of Ardelyx, Inc. Limited Shareholders
And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%. | Internet | Biotech Stock Review
Hyperphosphatemia Pipeline Insight Report 2023 (Updated)
Ardelyx to Raise $110 Million in a Private Placement
News & Events | Ardelyx, Inc.
Ardelyx, Inc. (NASDAQ: ARDX) Long Term Investor Notice: Lawsuit
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Ardelyx Stockholders and Encourages Investors to Contact the Firm | Business Wire
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page
SEC Filing | Ardelyx, Inc.
Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis
FY2023 Earnings Forecast for Ardelyx, Inc. (NASDAQ:ARDX) Issued By Cantor Fitzgerald - MarketBeat
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces $20 Million Financing Agreement with…
Ardelyx
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces Poster Presentations on XPHOZAH®…
Ardelyx
Ardelyx and Kyowa Hakko Kirin Announce License Agreement for Tenapanor for Cardiorenal Diseases in Japan
